Australian PM Morrison: Have no advice to change to AstraZeneca covid vaccine rollout


Australian Prime Minister Morrison said that he has no advice at present to change the AstraZeneca covid vaccine rollout.

This comes amid conflicting reports from the UK and Europe Health regulators.

On Wednesday, the European Medicines Agency (EMU) said that unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.

After a study looking at 86 European cases, the EMA concluded the benefits of the vaccine outweighed the risk.

Separately, the UK’s Medicines and Healthcare products Regulatory Agency considered outlining a proposal, which would restrict the use of the Oxford-AstraZeneca covid vaccine in younger people over concerns about very rare blood clots.

Meanwhile, the World Health Organization's (WHO) advisory vaccine safety panel said on Wednesday that although a blood clot link was "plausible" it was "not confirmed" and the cases were "very rare" among 200 million people vaccinated with AstraZeneca globally.

Market implications

The mixed vaccine reviews are boding ill for the Asian equities while the US dollar clings onto the overnight gains.

AUD/USD is attempting a rebound from 0.7600, now trading flat at 0.7614, lacking a follow-through bias.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.

Feed news

Get Weekly Crypto trade ideas!  
Empower yourself with the best market insights

Join FXStreet Premium!    

Latest Forex News


Latest Forex News

Editors’ Picks

EUR/USD slips from highs as investors await US Retail Sales

EUR/USD has backed down from the highs near 1.20 as the dollar benefits from the Fed's upbeat mood. All eyes are on US Retail Sales, which are set to leap. 

EUR/USD News

GBP/USD rises toward 1.38 ahead of US data, Brexit meeting

GBP/USD is edging up toward 1.38, reversing its previous falls in tense trading ahead of all-important US retail sales. A Brexit-related meeting on Northern Ireland is also eyed. 

GBP/USD News

Bitcoin on-chain data shows BTC is reaching “peak hype”

Bitcoin’s on-chain data suggest a short-term correction may be needed before Bitcoin could continue its price rally. Market sentiment toward Bitcoin poses a major concern for the cryptocurrency, indicating it is approaching “peak hype.”

Read more

XAU/USD looks to retest $1750 as USD bounce fizzles ahead of US Retail Sales

Gold is breaking higher as the US dollar rebound loses steam. The US Treasury yields retreat ahead of the Retail Sales release. XAU/USD is teasing symmetrical triangle breakout on the 1H chart.

Gold News

Coinbase (COIN) closes down 14% from the $381 opening price, what next?

After a dream debut for the cryptocurrency exchange Coinbase Global Inc. (COIN) on Nasdaq at $381, the shares rallied as high as $429.54. Although the upswing failed to sustain, as Bitcoin fell from record highs and tech stocks tumbled across the board. 

Read more

Forex MAJORS

Cryptocurrencies

Signatures